Working in more than 50 countries, The Health Policy Partnership has developed highly credible resources that help inform policymakers about key health issues and contribute to bringing about a step change in discussions and decisions in health policy.

‘HPP is an organised, experienced team with an unprecedented focus on communication and collaboration. They coordinate activity with a flexible approach to the fluctuations in needs of project tasks and participants, while maintaining momentum toward the objective at hand. They are detail-oriented and timely with responses, and they truly comprehend the perspectives of stakeholders with whom they work in any given aspect of health policy research and strategy.’

Kathy Barnard

President, Save Your Skin Foundation Canada

Health system sustainability and resilience

Early detection of lung cancer and reduction of hospitalisations in heart failure are crucial elements of improving the effectiveness of healthcare.

Heart valve disease

Heart valve disease is a serious condition which can be fatal if left untreated, yet it tends to receive less attention than other cardiovascular diseases.

Fragility Fracture Network policy toolkit

HPP supported the Fragility Fracture Network to produce toolkits for its members to support its Global Call to Action.

Brain tumours and COVID‑19

HPP co-authored a lay summary of findings from the International Brain Tumour Alliance and Society for Neuro-Oncology survey on how COVID-19 has affected brain tumour patients and carers around the world.

Achieving optimal care for women of childbearing age living with chronic diseases

The lack of evidence around medication use in pregnancy leaves many women with chronic diseases facing difficult choices about whether, and how, to start a family.

Adapting health and social care in the wake of COVID‑19

In June 2020, HPP developed a think piece exploring areas in which gaps exposed by the COVID-19 pandemic could be addressed to help build more robust health and social care systems.

Osteoporosis and fragility fractures

Osteoporosis – a chronic disease that weakens bones and leaves people at risk of a fragility fracture – is expected to become more common as populations age across Europe.

Radioligand therapy

Radioligand therapy is an innovative approach to treating certain types of cancer by delivering radiation to specifically targeted cancer cells, with a minimal effect on healthy cells.

Thyroid disorders in Latin America

Thyroid disorders occur when the thyroid gland produces insufficient or excess thyroid hormones, and can be particularly harmful for older people or pregnant women.

Rethinking MS

Multiple sclerosis is a neurological disorder that places unique challenges on health and social care systems, which must work together to ensure the needs and goals of every person with MS are met.

A life-course approach to immunisation

Programmes that support immunisation across the life course can improve population health and promote health system sustainability. International examples of best practice offer valuable lessons.

Non-alcoholic steatohepatitis

The progressive form of non‑alcoholic fatty liver disease, known as non‑alcoholic steatohepatitis (NASH), is a growing concern as the global prevalence of obesity and type 2 diabetes continues to rise.

Genetic testing for BRCA mutations

Genetic mutations in the BRCA1 and BRCA2 genes are associated with a significant risk of developing breast cancer, but many people who may carry these mutations cannot access genetic testing.

A sustainable approach to depression

Depression is on the rise, and the policy response has so far been insufficient, with huge gaps in care and underfunding of mental health services.

Atrial fibrillation and AF‑related stroke

Atrial fibrillation is a common condition and leading cause of stroke, yet is widely under-recognised and people across Europe face significant inequalities in access to detection and treatment.


As the incidence of cancer increases, healthcare systems must find effective and sustainable ways to care for all cancer patients – and radiotherapy is a key part of this.

Viral hepatitis in Asia Pacific

Global deaths from viral hepatitis continue to rise, and more than 60% occur in the Asia Pacific region.

Life-course vaccination

Vaccination is vital to improve population health throughout life – but despite strong evidence, it is misunderstood and undervalued.

Childhood epilepsy

The needs of children with epilepsy who experience prolonged convulsive seizures have been neglected – but these children may be at serious risk without effective treatment.

Sarcoma Policy Checklist

Despite advances in research and treatment in recent years, sarcoma patients report some of the poorest experiences of care among people with cancer.

Rare Diseases: shaping a future with no-one left behind

Rare diseases affect up to 400 million people across the world – and, for many, there are no treatment options available.

All.Can – changing cancer care together

All.Can is an international initiative working to improve efficiency in cancer care by focusing on what matters to patients.


Rare cancers represent almost a quarter of new cancer diagnoses in Europe – so improving patient outcomes should be a public health priority.

The state of play in person-centred care

A person-centred approach can transform a person’s experience of care, but a lack of common definitions and terminology may hinder its use in practice.

Metastatic breast cancer country reports

Despite great improvements in diagnosis and treatment, breast cancer remains the most frequent cause of cancer death in women worldwide.


Using the body’s own immune system to fight disease, immuno-oncology has transformed the prognosis for many types of cancer.

The Heart Failure Policy Network

HFPN is an independent, multidisciplinary network working across Europe to raise awareness of the unmet needs of people with heart failure.